Oaktree Capital racks up $2.3bn for inaugural life sciences lending fund

The fund will focus on sectors such as biopharma and medical devices.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this